Jazz Pharmaceuticals (ProstaScint Business) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Jazz Pharmaceuticals (ProstaScint Business) General Information

Description

Developer of pharmaceutical products. The company's harmaceutical product ProstaScint which is a is a murine monoclonal antibody conjugated to a linker-chelator that targets Prostate Specific Membrane Antigen (PSMA), detects metastases and extent of prostate cancer.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • CO
  • United States
Primary Industry
Pharmaceuticals
Acquirer
Vertical(s)
Corporate Office
  • CO
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Jazz Pharmaceuticals (ProstaScint Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Jazz Pharmaceuticals (ProstaScint Business)‘s full profile, request access.

Request a free trial

Jazz Pharmaceuticals (ProstaScint Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Jazz Pharmaceuticals (ProstaScint Business)‘s full profile, request access.

Request a free trial

Jazz Pharmaceuticals (ProstaScint Business) FAQs

  • Where is Jazz Pharmaceuticals (ProstaScint Business) headquartered?

    Jazz Pharmaceuticals (ProstaScint Business) is headquartered in CO.

  • What industry is Jazz Pharmaceuticals (ProstaScint Business) in?

    Jazz Pharmaceuticals (ProstaScint Business)’s primary industry is Pharmaceuticals.

  • Is Jazz Pharmaceuticals (ProstaScint Business) a private or public company?

    Jazz Pharmaceuticals (ProstaScint Business) is a Private company.

  • What is the current valuation of Jazz Pharmaceuticals (ProstaScint Business)?

    The current valuation of Jazz Pharmaceuticals (ProstaScint Business) is .

  • What is Jazz Pharmaceuticals (ProstaScint Business)’s current revenue?

    The current revenue for Jazz Pharmaceuticals (ProstaScint Business) is .

  • Who are Jazz Pharmaceuticals (ProstaScint Business)’s investors?

    Jazz Pharmaceuticals has invested in Jazz Pharmaceuticals (ProstaScint Business).

  • When was Jazz Pharmaceuticals (ProstaScint Business) acquired?

    Jazz Pharmaceuticals (ProstaScint Business) was acquired on 20-May-2015.

  • Who acquired Jazz Pharmaceuticals (ProstaScint Business)?

    Jazz Pharmaceuticals (ProstaScint Business) was acquired by Aytu Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »